These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16013961)

  • 1. Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies.
    Shukla SJ; Dolan ME
    Pharmacogenomics; 2005 Apr; 6(3):303-10. PubMed ID: 16013961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEPH individuals are representative of the European American population: implications for pharmacogenetics.
    Meucci MA; Marsh S; Watters JW; McLeod HL
    Pharmacogenomics; 2005 Jan; 6(1):59-63. PubMed ID: 15723606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity.
    Dolan ME; Newbold KG; Nagasubramanian R; Wu X; Ratain MJ; Cook EH; Badner JA
    Cancer Res; 2004 Jun; 64(12):4353-6. PubMed ID: 15205351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis.
    Shukla SJ; Duan S; Badner JA; Wu X; Dolan ME
    Pharmacogenet Genomics; 2008 Mar; 18(3):253-62. PubMed ID: 18300947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of thymidylate synthase variants with 5-fluorouracil cytotoxicity.
    Peters EJ; Kraja AT; Lin SJ; Yen-Revollo JL; Marsh S; Province MA; McLeod HL
    Pharmacogenet Genomics; 2009 May; 19(5):399-401. PubMed ID: 19339911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of population and gender on chemotherapeutic agent-induced cytotoxicity.
    Huang RS; Kistner EO; Bleibel WK; Shukla SJ; Dolan ME
    Mol Cancer Ther; 2007 Jan; 6(1):31-6. PubMed ID: 17237264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic association/linkage of sodium lithium countertransport in CEPH pedigrees.
    Schork NJ; Gardner JP; Zhang L; Fallin D; Thiel B; Jakubowski H; Aviv A
    Hypertension; 2002 Nov; 40(5):619-28. PubMed ID: 12411453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy number increase of 1p36.33 and mitochondrial genome amplification in Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Jeon JP; Shim SM; Nam HY; Baik SY; Kim JW; Han BG
    Cancer Genet Cytogenet; 2007 Mar; 173(2):122-30. PubMed ID: 17321327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines.
    Stark AL; Zhang W; Mi S; Duan S; O'Donnell PH; Huang RS; Dolan ME
    Pharmacogenomics J; 2010 Dec; 10(6):505-12. PubMed ID: 20142840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide discovery of loci influencing chemotherapy cytotoxicity.
    Watters JW; Kraja A; Meucci MA; Province MA; McLeod HL
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11809-14. PubMed ID: 15282376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping genes that contribute to daunorubicin-induced cytotoxicity.
    Duan S; Bleibel WK; Huang RS; Shukla SJ; Wu X; Badner JA; Dolan ME
    Cancer Res; 2007 Jun; 67(11):5425-33. PubMed ID: 17545624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype instability during long-term subculture of lymphoblastoid cell lines.
    Oh JH; Kim YJ; Moon S; Nam HY; Jeon JP; Lee JH; Lee JY; Cho YS
    J Hum Genet; 2013 Jan; 58(1):16-20. PubMed ID: 23171997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants contributing to daunorubicin-induced cytotoxicity.
    Huang RS; Duan S; Kistner EO; Bleibel WK; Delaney SM; Fackenthal DL; Das S; Dolan ME
    Cancer Res; 2008 May; 68(9):3161-8. PubMed ID: 18451141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of immortalized lymphoblastoid cell bank of a keloid pedigree].
    Yan X; Gao JH; Song M; Liu XJ; Chen Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):22-4. PubMed ID: 16495169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consanguinity in Centre d'Étude du Polymorphisme Humain (CEPH) pedigrees.
    Stevens EL; Heckenberg G; Baugher JD; Roberson ED; Downey TJ; Pevsner J
    Eur J Hum Genet; 2012 Jun; 20(6):657-67. PubMed ID: 22274586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can pharmacogenetics help rescue drugs withdrawn from the market?
    Shah RR
    Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human lymphoblastoid cell lines: a goldmine for the biobankomics era.
    Nam HY; Shim SM; Han BG; Jeon JP
    Pharmacogenomics; 2011 Jun; 12(6):907-17. PubMed ID: 21692620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of genetic and epigenetic variation affecting human gene expression.
    Pastinen T; Sladek R; Gurd S; Sammak A; Ge B; Lepage P; Lavergne K; Villeneuve A; Gaudin T; Brändström H; Beck A; Verner A; Kingsley J; Harmsen E; Labuda D; Morgan K; Vohl MC; Naumova AK; Sinnett D; Hudson TJ
    Physiol Genomics; 2004 Jan; 16(2):184-93. PubMed ID: 14583597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro human cell line models to predict clinical response to anticancer drugs.
    Niu N; Wang L
    Pharmacogenomics; 2015; 16(3):273-85. PubMed ID: 25712190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.